Sign in

NCT07074158Enrolling by invitation

Microbial and Cytokine Signatures in Long COVID Patients

Identification of Microbial and Cytokine Signatures in Long COVID Patients: A Case-control Study of Long COVID Patients With Healthy Individuals

Source: ClinicalTrials.gov · Last updated 20 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

We aim at identifying potential biomarkers in plasma indicative of post-acute coronavirus SARS-CoV-2 Syndrome (Long COVID). Our case-control study will compare Long COVID patients to healthy patients from Sutter Health.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
150 (estimated)
First submitted
11 Jul 2025
Start date
14 Jul 2025
Primary completion date
13 Jul 2026
Lead sponsor
Palo Alto Medical Foundation
NCT number
NCT07074158

What you commit to

  • Study type: Observational
  • Planned participants: 150
  • From 14 Jul 2025 to the primary completion date, 13 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Alcohol or another drug abuse ongoing within one year

Other illness

  • Bipolar disorder, schizophrenia, or other psychosis
  • History of malignancy, except basal cell carcinoma
  • History of significant autoimmune disorder:
    • Addison disease
    • Dermatomyositis
    • Graves' disease
    • Multiple sclerosis
    • Myasthenia gravis
    • Pernicious anemia
    • Rheumatoid arthritis
    • Sjögren syndrome
    • Systemic lupus erythematosus
    • Type I diabetes
    • Celiac disease
  • Active pulmonary infection (active pneumonia)
  • Chronic kidney disease
  • Chronic liver disease
  • Chronic lung disease
  • Interstitial pneumonitis
  • Chronic obstructive pulmonary disease (COPD)
  • Immunocompromised conditions or weaken immune system:
    • Cancer under treatment or treated within one year of enrollment
    • AIDS
    • Transplant patient
  • Neurologic conditions:
    • Dementia or other neurological conditions
    • Acute Spinal Cord Injury
    • Alzheimer's Disease
    • Amyotrophic Lateral Sclerosis (ALS)
    • Ataxia
    • Cerebral Aneurysm diagnosed within one year of enrollment
    • Epilepsy and Seizures uncontrolled with medication
  • Heart conditions:
    • Congestive heart failure
    • Myocardial infarction

Other

  • Pregnant or nursing woman
  • Severe depression or acute suicidal ideation
  • Pulmonary fibrosis
  • Uncontrolled asthma
  • Reactive arthritis
  • Biologicals impacting the immune system
  • Taking immunosuppressor

Who the study is looking for

  • ≥ 18-year-old
  • English speaking (per Sutter medical records information)
  • Ability and willingness to provide signed Consent Form
  • Ability to comply with the study protocol
  • Ability to attend the study visit, complete questionnaires, have blood collected and tested And, either Long-COVID or Healthy control as described below
  • Long-COVID patient Cohort (n=75)
    • Sutter patient who is a patient from Sutter Health Holistic/Integrative Medicine clinic
    • Documentation of a long-COVID diagnosis (U09.9) for patient's initial visit in clinic between 01/01/2021 and 06/30/2024.
    • Presence of active and ongoing long-COVID symptoms
    • Ongoing long-COVID symptoms consistently present over the previous 6 months or longer
    • Presence of the following long-COVID symptoms (a, b, and c plus either d or e) affecting you more than 50% of your life:
    • Fatigue that does not go away with rest.
    • Post-exertional malaise ((worsening of your symptoms following cognitive, emotional, physical efforts)
    • Unrefreshing sleep (sleep is not restorative)
    • Brain "fog" (e.g., difficulty with finding words or mental tasks)
    • Postural Orthostatic Hypotension (e.g., lightheadedness, dizziness, and/or palpitations with sitting up or standing up positions).
  • Healthy controls with no Long COVID syndrome (n=75)
    • Sutter Health patients
    • Matched by age to a long COVID subject (+/-10 years and preferably by sex).

Age in the registry: 18 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sutter Health Palo Alto Center
Coordinator of this site? Confirm its status
Palo AltoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.